{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:25:34Z","timestamp":1768742734413,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>More than three billion populations are living under the threat of Japanese encephalitis in South East Asian (SEA) countries including India. The pathogenesis of this disease is not clearly understood and is probably attributed to genomic variations in viral strains as well as the host genetic makeup. The present study is to determine the role of polymorphism of TNF-alpha promoter regions at positions -238G\/A, -308G\/A, -857C\/T and -863C\/A in the severity of Japanese encephalitis patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Total of 142 patients including 66 encephalitis case (IgM\/RT-PCR positive), 16 fever cases (IgM positive) without encephalitis and 60 apparently healthy individuals (IgG positive) were included in the study. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) using site specific restriction enzymes were implemented for polymorphism study of TNF alpha promoter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Following the analysis of the digestion patterns of four polymorphic sites of the TNF- alpha promoter region, a significant association was observed between the allele -308A and -863C with the patients of Japanese encephalitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>TNF- alpha 308 G\/A has been shown to be associated with elevated TNF- alpha transcriptional activity. On the other hand, polymorphism at position -863C\/A in the promoter region has been reported to be associated with reduced TNF- alpha promoter activity and lower plasma TNF levels. As per the literature search, this is the first study to identify the role of TNF- alpha promoter in JE infection. Our results show that subjects with - 308A and -863C alleles are more vulnerable to the severe form of JE infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-23","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T07:24:09Z","timestamp":1327562649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["TNF-\u03b1 promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis"],"prefix":"10.1186","volume":"12","author":[{"given":"Sujit Kumar","family":"Pujhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha Kanta","family":"Ratho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudesh","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baijayantimala","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"1750_CR1","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1038\/nm1144","volume":"10","author":"JS Mackenzie","year":"2004","unstructured":"Mackenzie JS, Gubler DJ, Petersen LR: Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004, 10: S98-S109. 10.1038\/nm1144.","journal-title":"Nat Med"},{"key":"1750_CR2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1999.tb127878.x","volume":"170","author":"JN Hanna","year":"1999","unstructured":"Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, Pyke AT, Johansen CA, Mackenzie JS: Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust. 1999, 170: 533-536.","journal-title":"Med J Aust"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.2310\/7060.2005.12052","volume":"12","author":"LR Petersen","year":"2005","unstructured":"Petersen LR, Marfin AA: Shifting epidemiology of Flaviviridae. J Travel Med. 2005, 12: S3-S11.","journal-title":"J Travel Med"},{"key":"1750_CR4","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","volume":"77","author":"T Solomon","year":"2003","unstructured":"Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD: Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003, 77: 3091-3098. 10.1128\/JVI.77.5.3091-3098.2003.","journal-title":"J Virol"},{"key":"1750_CR5","first-page":"78","volume":"37","author":"P Rao","year":"2005","unstructured":"Rao P, Joshi K, Mishra B, Ratho RK, Kumar R: An outbreak of Japanese encephalitis in Haryana. J Commun Dis. 2005, 37: 78-81.","journal-title":"J Commun Dis"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/13550280390194037","volume":"9","author":"T Solomon","year":"2003","unstructured":"Solomon T: Recent advances in Japanese encephalitis. J Neurovirol. 2003, 9: 274-283.","journal-title":"J Neurovirol"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","volume":"75","author":"J Arroyo","year":"2001","unstructured":"Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ: Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol. 2001, 75: 934-942. 10.1128\/JVI.75.2.934-942.2001.","journal-title":"J Virol"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1099\/0022-1317-77-7-1449","volume":"77","author":"H Ni","year":"1996","unstructured":"Ni H, Barrett AD: Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol. 1996, 77: 1449-1455. 10.1099\/0022-1317-77-7-1449.","journal-title":"J Gen Virol"},{"key":"1750_CR9","first-page":"1","volume":"23","author":"SK Pujhari","year":"2010","unstructured":"Pujhari SK, Prabhakar S, Ratho RK, Modi M, Sharma M, Mishra B: A novel mutation (S227T) in domain II of the envelope gene of Japanese encephalitis virus circulating in North India. Epidemiol Infect. 2010, 23: 1-8.","journal-title":"Epidemiol Infect"},{"key":"1750_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8","volume":"51","author":"V Ravi","year":"1997","unstructured":"Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau GE: Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol. 1997, 51: 132-136. 10.1002\/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8.","journal-title":"J Med Virol"},{"key":"1750_CR11","first-page":"1153","volume":"168","author":"R Long","year":"2003","unstructured":"Long R, Gardam M: Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. Cmaj. 2003, 168: 1153-1156.","journal-title":"Cmaj"},{"key":"1750_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/sj.gene.6364072","volume":"5","author":"CL Thio","year":"2004","unstructured":"Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brien SJ, Astemborski J, Thomas DL: An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun. 2004, 5: 294-300. 10.1038\/sj.gene.6364072.","journal-title":"Genes Immun"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1128\/IAI.70.12.6919-6925.2002","volume":"70","author":"TM Karplus","year":"2002","unstructured":"Karplus TM, Jeronimo SM, Chang H, Helms BK, Burns TL, Murray JC, Mitchell AA, Pugh EW, Braz RF, Bezerra FL, et al: Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun. 2002, 70: 6919-6925. 10.1128\/IAI.70.12.6919-6925.2002.","journal-title":"Infect Immun"},{"key":"1750_CR14","first-page":"5213","volume":"11","author":"HQ Li","year":"2005","unstructured":"Li HQ, Li Z, Liu Y, Li JH, Dong JQ, Gao JR, Gou CY, Li H: Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol. 2005, 11: 5213-5217.","journal-title":"World J Gastroenterol"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/hmg\/ddg262","volume":"12","author":"YJ Kim","year":"2003","unstructured":"Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD: Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003, 12: 2541-2546. 10.1093\/hmg\/ddg262.","journal-title":"Hum Mol Genet"},{"key":"1750_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1365-2249.1998.00534.x","volume":"111","author":"T Hohler","year":"1998","unstructured":"Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C: A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998, 111: 579-582. 10.1046\/j.1365-2249.1998.00534.x.","journal-title":"Clin Exp Immunol"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/371508a0","volume":"371","author":"W McGuire","year":"1994","unstructured":"McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994, 371: 508-510. 10.1038\/371508a0.","journal-title":"Nature"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/00365540802227102","volume":"40","author":"R Swami","year":"2008","unstructured":"Swami R, Ratho RK, Mishra B, Singh MP: Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples. Scand J Infect Dis. 2008, 40: 815-820. 10.1080\/00365540802227102.","journal-title":"Scand J Infect Dis"},{"key":"1750_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1471-2334-9-214","volume":"9","author":"S Hills","year":"2009","unstructured":"Hills S, Dabbagh A, Jacobson J, Marfin A, Featherstone D, Hombach J, Namgyal P, Rani M, Solomon T: Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis. 2009, 9: 214-10.1186\/1471-2334-9-214.","journal-title":"BMC Infect Dis"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2893.2006.00731.x","volume":"13","author":"T Du","year":"2006","unstructured":"Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H: Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat. 2006, 13: 618-624. 10.1111\/j.1365-2893.2006.00731.x.","journal-title":"J Viral Hepat"},{"key":"1750_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2958.1992.tb01505.x","volume":"6","author":"X Nassif","year":"1992","unstructured":"Nassif X, Mathison JC, Wolfson E, Koziol JA, Ulevitch RJ, So M: Tumour necrosis factor alpha antibody protects against lethal meningococcaemia. Mol Microbiol. 1992, 6: 591-597. 10.1111\/j.1365-2958.1992.tb01505.x.","journal-title":"Mol Microbiol"},{"key":"1750_CR22","doi-asserted-by":"publisher","first-page":"10349","DOI":"10.1128\/JVI.00935-08","volume":"82","author":"S Daffis","year":"2008","unstructured":"Daffis S, Samuel MA, Suthar MS, Gale M, Diamond MS: Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008, 82: 10349-10358. 10.1128\/JVI.00935-08.","journal-title":"J Virol"},{"key":"1750_CR23","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/nm1140","volume":"10","author":"T Wang","year":"2004","unstructured":"Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004, 10: 1366-1373. 10.1038\/nm1140.","journal-title":"Nat Med"},{"key":"1750_CR24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1086\/427826","volume":"191","author":"A Deshpande","year":"2005","unstructured":"Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM: TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis. 2005, 191: 969-976. 10.1086\/427826.","journal-title":"J Infect Dis"},{"key":"1750_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jmv.21688","volume":"82","author":"SM Biswas","year":"2010","unstructured":"Biswas SM, Kar S, Singh R, Chakraborty D, Vipat V, Raut CG, Mishra AC, Gore MM, Ghosh D: Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. J Med Virol. 2010, 82: 304-310. 10.1002\/jmv.21688.","journal-title":"J Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:39:17Z","timestamp":1630521557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-23","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]},"assertion":[{"value":"18 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}